Bitter melon triterpenes work as insulin sensitizers and insulin substitutes in insulin-resistant cells

Journal of Functional Foods

Volumn 13, Issue , 2015, Pages 214-224

  Chang, Chi I ^a   Chou, Chang Hung ^b   Liao, Ming Huei ^a   Chen, Tz Min ^a   Cheng, Chia Hsin ^a   Anggriani, Rista ^a,c   Tsai, Chung Pao ^a   Tseng, Hsin I ^a   Cheng, Hsueh Ling ^a  

^a NATIONAL PINGTUNG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Taiwan)

^b CHINA MEDICAL UNIVERSITY   (Taiwan)

^c BRAWIJAYA UNIVERSITY   (Indonesia)

Author keywords

AMP activated protein kinase; Insulin resistance; Insulin substitution; Momordica charantia; Protein tyrosine phosphatase 1B; Triterpene

Indexed keywords

CUCUMIS; MOMORDICA CHARANTIA;

EID: 84922534366     PISSN: 17564646     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jff.2014.12.050     Document Type: Article

References (49)

1. Baboota R.K., Bishnoi M., Ambalam P., Kondepudi K.K., Sarma S.M., Boparai R.K., Podili K. Functional food ingredients for the management of obesity and associated co-morbidities - A review. Journal of Functional Foods 2013, 5:997-1012.
2. Bagul P.K., Middela H., Matapally S., Padiya R., Bastia T., Madhusudana K., Reddy B.R., Chakravarty S., Banerjee S.K. Attenuation of insulin resistance, metabolic syndrome and hepatic oxidative stress by resveratrol in fructose-fed rats. Pharmacological Research 2012, 66:260-268.
3. Baumgartner R.R., Steinmann D., Heiss E.H., Atanasov A.G., Ganzera M., Stuppner H., Dirsch V.M. Bioactivity-guided isolation of 1,2,3,4,6-penta-O-galloyl-D-glucopyranose from Paeonia lactiflora roots as a PTP1B inhibitor. Journal of Natural Products 2010, 73:1578-1581.
4. Chang C.I., Chen C.R., Liao Y.W., Cheng H.L., Chen Y.C., Chou C.H. Cucurbitane-type triterpenoids from the stems of Momordica charantia. Journal of Natural Products 2008, 71:1327-1330.
5. Chang C.I., Hsu C.M., Li T.S., Huang S.D., Lin C.C., Yen C.H., Chou C.H., Cheng H.L. Constituents of the stem of Cucurbita moschata exhibit antidiabetic activities through multiple mechanisms. Journal of Functional Foods 2014, 10:260-273.
6. Chang C.I., Tseng H.I., Liao Y.W., Yen C.H., Chen T.M., Lin C.C., Cheng H.L. In vivo and in vitro studies to identify the hypoglycaemic constituents of Momordica charantia wild variant WB24. Food Chemistry 2011, 125:521-528.
7. Chen C., Zhang Y., Huang C. Berberine inhibits PTP1B activity and mimics insulin action. Biochemical and Biophysical Research Communications 2010, 397:543-547.
8. Chen L.N., Lyu J., Yang X.F., Ji W.J., Yuan B.X., Chen M.X., Ma X., Wang B. Liraglutide ameliorates glycometabolism and insulin resistance through the upregulation of GLUT4 in diabetic KKAy mice. International Journal of Molecular Medicine 2013, 32:892-900.
9. Cip1/Waf1 promoter-driven reporter systems during camptothecin-induced senescence-like state of BHK-21 cells. Molecular and Cellular Biochemistry 2006, 291:29-38.
10. Cheng H.L., Huang H.K., Chang C.I., Tsai C.P., Chou C.H. A cell-based screening identifies compounds from the stem of Momordica charantia that overcome insulin resistance and activate AMP-activated protein kinase. Journal of Agricultural and Food Chemistry 2008, 56:6835-6843.
11. Cheng H.L., Kuo C.Y., Liao Y.W., Lin C.C. EMCD, a hypoglycemic triterpene isolated from Momordica charantia wild variant, attenuates TNF-alpha-induced inflammation in FL83B cells in an AMP-activated protein kinase-independent manner. European Journal of Pharmacology 2012, 689:241-248.
12. Chung M.J., Cho S.Y., Bhuiyan M.J., Kim K.H., Lee S.J. Anti-diabetic effects of lemon balm (Melissa officinalis) essential oil on glucose- and lipid-regulating enzymes in type 2 diabetic mice. British Journal of Nutrition 2010, 104:180-188.
13. Ding Y.P., Ye X.L., Zhu J.Y., Zhu X.K., Li X.G., Chen B.C. Structural modification of berberine alkaloid and their hypoglycemic activity. Journal of Functional Foods 2014, 7:229-237.
14. Gould G.W., Holman G.D. The glucose transporter family: Structure, function and tissue-specific expression. Biochemical Journal 1993, 295:329-341.
15. Grover J.K., Yadav S.P. Pharmacological actions and potential uses of Momordica charantia: A review. Journal of Ethnopharmacology 2004, 93:123-132.
16. Hardie D.G. AMPK: A target for drugs and natural products with effects on both diabetes and cancer. Diabetes 2013, 62:2164-2172.
17. Harinantenaina L., Tanaka M., Takaoka S., Oda M., Mogami O., Uchida M., Asakawa Y. Momordica charantia constituents and antidiabetic screening of the isolated major compounds. Chemical & Pharmaceutical Bulletin 2006, 54:1017-1021.
18. Hirabara S.M., Gorjao R., Vinolo M.A., Rodrigues A.C., Nachbar R.T., Curi R. Molecular targets related to inflammation and insulin resistance and potential interventions. Journal of Biomedicine and Biotechnology 2012, 2012:379024.
19. Hoffler U., Hobbie K., Wilson R., Bai R., Rahman A., Malarkey D., Travlos G., Ghanayem B.I. Diet-induced obesity is associated with hyperleptinemia, hyperinsulinemia, hepatic steatosis, and glomerulopathy in C57Bl/6J mice. Endocrine 2009, 36:311-325.
20. Hu X., Zhao Y., He X., Li J., Wang T., Zhou W., Wan D., Wang H., Gu J. Ciliary neurotrophic factor receptor alpha subunit-modulated multiple downstream signaling pathways in hepatic cancer cell lines and their biological implications. Hepatology 2008, 47:1298-1308.
21. Huang S.H., Czech M.P. The GLUT4 glucose transporter. Cell Metabolism 2007, 5:237-252.
22. Jiang B., Guo S., Shi D., Guo C., Wang T. Discovery of novel bromophenol 3,4-dibromo-5-(2-bromo-3,4-dihydroxy-6-(isobutoxymethyl)benzyl)benzene-1,2-diol as protein tyrosine phosphatase 1B inhibitor and its anti-diabetic properties in C57BL/KsJ-db/db mice. European Journal of Medicinal Chemistry 2013, 64:129-136.
23. Jin J., Wang G.L., Iakova P., Shi X., Haefliger S., Finegold M., Timchenko N.A. Epigenetic changes play critical role in age-associated dysfunctions of the liver. Aging Cell 2010, 9:895-910.
24. Jornayvaz F.R., Samuel V.T., Shulman G.I. The role of muscle insulin resistance in the pathogenesis of atherogenic dyslipidemia and nonalcoholic fatty liver disease associated with the metabolic syndrome. Annual Review of Nutrition 2010, 30:273-290.
25. Karim S., Adams D.H., Lalor P.F. Hepatic expression and cellular distribution of the glucose transporter family. World Journal of Gastroenterology 2012, 18:6771-6781.
26. Kolb H., Mandrup-Poulsen T. The global diabetes epidemic as a consequence of lifestyle-induced low-grade inflammation. Diabetologia 2010, 53:10-20.
27. Leclercq I.A., Da Silva Morais A., Schroyen B., Van Hul N., Geerts A. Insulin resistance in hepatocytes and sinusoidal liver cells: Mechanisms and consequences. Journal of Hepatology 2007, 47:142-156.
28. Li S.P., Li W., Wang Y.H., Asada Y., Koike K. Prenylflavonoids from Glycyrrhiza uralensis and their protein tyrosine phosphatase-1B inhibitory activities. Bioorganic & Medicinal Chemistry Letters 2010, 20:5398-5401.
29. Lo H.Y., Ho T.Y., Li C.C., Chen J.C., Liu J.J., Hsiang C.Y. A novel insulin receptor-binding protein from Momordica charantia enhances glucose uptake and glucose clearance in vitro and in vivo through triggering insulin receptor signaling pathway. Journal of Agricultural and Food Chemistry 2014, 62:8952-8961.
30. Nerurkar P.V., Lee Y.K., Motosue M., Adeli K., Nerurkar V.R. Momordica charantia (bitter melon) reduces plasma apolipoprotein B-100 and increases hepatic insulin receptor substrate and phosphoinositide-3 kinase interactions. British Journal of Nutrition 2008, 100:751-759.
31. Nevado C., Valverde A.M., Benito M. Role of insulin receptor in the regulation of glucose uptake in neonatal hepatocytes. Endocrinology 2006, 147:3709-3718.
32. Nieto-Vazquez I., Fernandez-Veledo S., de Alvaro C., Rondinone C.M., Valverde A.M., Lorenzo M. Protein-tyrosine phosphatase 1B-deficient myocytes show increased insulin sensitivity and protection against tumor necrosis factor-alpha-induced insulin resistance. Diabetes 2007, 56:404-413.
33. Popov D. Novel protein tyrosine phosphatase 1B inhibitors: Interaction requirements for improved intracellular efficacy in type 2 diabetes mellitus and obesity control. Biochemical and Biophysical Research Communications 2011, 410:377-381.
34. Rangwala S.M., Lazar M.A. Peroxisome proliferator-activated receptor gamma in diabetes and metabolism. Trends in Pharmacological Sciences 2004, 25:331-336.
35. Reddy M.V.V.V.S., Chakshusmathi G., Narasu M.L. Small molecule inhibitors of PTP1B and TCPTP. International Journal of Pharmaceutical and Phytopharmacological Research 2012, 1:287-291.
36. Saltiel A.R., Kahn C.R. Insulin signalling and the regulation of glucose and lipid metabolism. Nature 2001, 414:799-806.
37. Sato M., Tai T., Nunoura Y., Yajima Y., Kawashima S., Tanaka K. Dehydrotrametenolic acid induces preadipocyte differentiation and sensitizes animal models of noninsulin-dependent diabetes mellitus to insulin. Biological and Pharmaceutical Bulletin 2002, 25:81-86.
38. Sidor A., Gramza-Michałowska A. Advanced research on the antioxidant and health benefit of elderberry (Sambucus nigra) in food - A review. Journal of Functional Foods 2015, 10.1016/j.jff.2014.07.012.
39. Tan M.J., Ye J.M., Turner N., Hohnen-Behrens C., Ke C.Q., Tang C.P., Chen T., Weiss H.C., Gesing E.R., Rowland A., James D.E., Ye Y. Antidiabetic activities of triterpenoids isolated from bitter melon associated with activation of the AMPK pathway. Chemistry and Biology 2008, 15:263-273.
40. Tang W., Li S., Liu Y., Huang M.T., Ho C.T. Anti-diabetic activity of chemically profiled green tea and black tea extracts in a type 2 diabetes mice model via different mechanisms. Journal of Functional Foods 2013, 5:1784-1793.
41. Tang Y.C., Chen A.P. Curcumin prevents leptin raising glucose levels in hepatic stellate cells by blocking translocation of glucose transporter-4 and increasing glucokinase. British Journal of Pharmacology 2010, 161:1137-1149.
42. Watson R.T., Pessin J.E. Bridging the GAP between insulin signaling and GLUT4 translocation. Trends in Biochemical Sciences 2006, 31:215-222.
43. Whitehead J.P., Clark S.F., Urso B., James D.E. Signalling through the insulin receptor. Current Opinion in Cell Biology 2000, 12:222-228.
44. Wu C.H., Chen S.C., Ou T.T., Chyau C.C., Chang Y.C., Wang C.J. Mulberry leaf polyphenol extracts reduced hepatic lipid accumulation involving regulation of adenosine monophosphate activated protein kinase and lipogenic enzymes. Journal of Functional Foods 2013, 5:1620-1632.
45. Xie W., Du L. Diabetes is an inflammatory disease: Evidence from traditional Chinese medicines. Diabetes Obesity & Metabolism 2011, 13:289-301.
46. Yang H.J., Jang D.J., Hwang J.T. Anti-diabetic effects of Korean red pepper via AMPK and PPAR-gamma activation in C2C12 myotubes. Journal of Functional Foods 2012, 4:552-558.
47. Zabolotny J.M., Kim Y.B., Welsh L.A., Kershaw E.E., Neel B.G., Kahn B.B. Protein-tyrosine phosphatase 1B expression is induced by inflammation in vivo. Journal of Biological Chemistry 2008, 283:14230-14241.
48. Zhang L.J., Liaw C.C., Hsiao P.C., Huang H.C., Lin M.J., Lin Z.H., Hsu F.L., Kuo Y.H. Cucurbitane-type glycosides from the fruits of Momordica charantia and their hypoglycaemic and cytotoxic activities. Journal of Functional Foods 2014, 6:564-574.
49. Zhao F.Q., Keating A.F. Functional properties and genomics of glucose transporters. Current Genomics 2007, 8:113-128.